Navigation Links
One gene, many tissues
Date:3/27/2014

Genes are the "code" for building the biological elements that form an organism. The DNA that makes up genes contains the instructions to synthesise proteins, but it's wrong to think that, for a given gene, these instructions are always the same for all parts of the organisms. In actual fact, the gene varies depending on the tissue where it is located (cerebral cortex, cerebellum, olfactory epithelium, etc.); in particular, what varies is the point in the "string" of code at which protein synthesis starts. This complexity complicates the work of scientists considerably, but projects like FANTOM come to their aid. FANTOM is in fact an international consortium that brings together several dozens of laboratories worldwide and has recently published a paper providing an exhaustive map of these specificities. The Neurogenomics Laboratory of SISSA, coordinated by Stefano Gustincich is among the participating laboratories.

"FANTOM has existed for about fourteen years and the published paper is the result of the fifth phase of the project," explains Stefano Gustincich. "Each of the participating laboratories sent in several biological samples all of which were examined using the same methodology".

In particular, the researchers used CAGE technology which, unlike more traditional methods, analyses only the first nucleotides of messenger RNA. Messenger RNA is a small piece of genetic material that the DNA uses to sythesize proteins, a sort of carbon copy of part of the information contained in the gene. Nucleotides are the small beads that make up the "string" of DNA and RNA. "By analysing the first nucleotides we are able to identify which sequence of gene starts the transcription. For any given gene, this sequence in fact changes depending on the tissue in which it is located. This way, we know where the gene starts to do its work" continues Gustincich. "Finding the beginning of the active portion also enables us to identify the 'promoter', that is, the DNA sequence that precedes the actual gene". The promoter changes from tissue to tissue, and it is the part that regulates the "active" portion of the gene. The FANTOM project has drawn up a list of all the promoters in human and mouse genomes.

"It's a huge task and the results described in this first paper are only the more general findings", continues Gustincich. "Soon, however, the work of each of the single laboratories will start to be published which will provide details about the single tissues and genes analysed". In the case of SISSA's Neurobiology Laboratory, the focus was on the genes of olfactory receptors which, surprisingly, are also present in the cells that synthesise dopamine and that die in Parkinson's disease.


'/>"/>

Contact: federica sgorbissa
pressroom@sissa.it
39-040-378-7644
International School of Advanced Studies (SISSA)
Source:Eurekalert  

Related biology news :

1. One gene, many mutations
2. New biological scaffold offers promising foundation for engineered tissues
3. An essential step toward printing living tissues
4. Regenerating orthopedic tissues within the human body
5. Researchers regrow hair, cartilage, bone, soft tissues
6. Fetal tissue-derived stem cells may be ideal source for repairing tissues and organs
7. New protocol developed to decontaminate human fetal tissues used for cell transplantation
8. Ovarian cancer metastases influenced by factors in target tissues
9. Stem cell-based bioartificial tissues and organs
10. New methods for quantifying antisense drug delivery to target cells and tissues
11. 3-D biomimetic scaffolds support regeneration of complex tissues from stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
One gene, many tissues
(Date:1/12/2017)... research undertaken by Fit Small Business has revealed ... simply asked which office technology had they not used in ... Insights on what will be key features in ... industry leaders including Penelope Trunk , Martin Lindstrom ... Some of these findings included; ...
(Date:1/6/2017)... JOLLA, Calif. , Jan. 6, 2017 /PRNewswire/ ... 1 safety studies in healthy volunteers of a ... intended to treat acute pancreatitis. ... is typically a mild disorder, but can be ... organ failure and sepsis, where extended hospital stays, ...
(Date:1/4/2017)... , Jan. 4, 2017  CES 2017 – ... sensor technology, today announced the launch of two ... systems, the highly-accurate biometric sensor modules that incorporate ... technology, experience and expertise. The two new designs ... specifically for hearables, and Benchmark BW2.0, a 2-LED ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... -- Aratana Therapeutics, Inc. (NASDAQ: PETX ), ... and commercialization of innovative biopharmaceutical products for companion animals, ... North America 2016. ... the FDA approval of three innovative therapeutics in 2016, ... oral solution) and NOCITA ® (bupivacaine liposome injectable ...
(Date:1/20/2017)... http://www.Financialbuzz.com - According ... causes of death worldwide. There were 8.2 million cancer ... related deaths increased gradually over time, the death rates ... various cancers continues to drive demand of biological therapies ... Market Insights, Inc. cancer biological therapy market size was USD ...
(Date:1/19/2017)... 19, 2017 /PRNewswire -- WuXi AppTec, a leading ... and technology platform, today announced that it has ... preclinical drug discovery contract research organization (CRO). After ... wholly-owned subsidiary of WuXi, and will continue to ... greater services. The acquisition will further strengthen WuXi,s ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., ... Schmidt , Ph.D., as chief executive officer, as ... directors. Dr. Schmidt brings to ArmaGen more than 17 ... research and development of biotherapeutics and pharmaceuticals. ... with the diverse experience and skillset necessary to ...
Breaking Biology Technology: